Setiawan, Veronica Wendy <br/><br/>
CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).  [electronic resource] 

 -  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology  Nov 2007 
 - 2237-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1055-9965 
<br/><br/><label>Standard No.: </label>10.1158/1055-9965.EPI-07-0589  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--enzymology<br/>Case-Control Studies<br/>Cohort Studies<br/>Cooperative Behavior<br/>Female<br/>Genetic Predisposition to Disease<br/>Genetic Variation<br/>Gonadal Steroid Hormones--metabolism<br/>Haplotypes<br/>Humans<br/>Male<br/>Mutation, Missense<br/>Polymorphism, Single Nucleotide<br/>Postmenopause--metabolism<br/>Prostatic Neoplasms--enzymology<br/>Steroid 17-alpha-Hydroxylase--genetics